Cardiology

Trials, guidelines and practice across cardiovascular medicine.

Pre-existing CVD sharply raises ICI cardiovascular event risk

Pre-existing cardiovascular disease markedly increased cardiovascular events and mortality in patients receiving immune checkpoint inhibitors in a Saudi cohort.

By Dr. Aishwarya N., MBBS · Oct 23, 2026 · 5 min read

Cardiology·BMJ

Subclinical ICI Myocarditis Needs Better Screening and Risk Stratification

A BMJ rapid response argues that subclinical immune-checkpoint-inhibitor myocarditis needs clearer screening rules, risk stratification, and real-world data.

Oct 22, 2026

Cardiology·BMJ

Medical device surveillance needs registries and transparent reporting

BMJ editorial argues that device safety monitoring needs both public adverse event reporting and registries to improve accuracy,…

Oct 22, 2026

Cardiology·medRxiv

Respiratory Failure Mortality With AF Rises Sharply in Older U.S. Adults

CDC WONDER analysis found a fivefold rise in respiratory failure deaths with co-listed atrial fibrillation among U.S. adults…

Oct 22, 2026

Cardiology·Sci Transl Med

SIK2 Impairs Cardiac Repair After Myocardial Infarction

A mechanistic study links SIK2 to worse postinfarction cardiac repair by promoting inflammatory macrophages and weakening efferocytosis.

Oct 22, 2026

Cardiology·Sci Transl Med

SIK2 disrupts cardiac repair after infarction by reprogramming macrophages

Science Translational Medicine reports that SIK2 impairs postinfarction cardiac repair by promoting inflammatory macrophages and blocking efferocytosis.

Oct 22, 2026

Cardiology·JACC

AI in Remote Monitoring of Cardiac Devices Faces Data and Privacy Barriers

A narrative review describes how AI may reduce alert fatigue in cardiac device monitoring, but adoption depends on…

Oct 22, 2026

Cardiology·Nature

Podcast education improved hypertension self-care in randomized trial

A randomized trial in hypertension found podcast-supported education improved self-care management and treatment adherence versus conventional teaching.

Oct 22, 2026

Cardiology·Nature

VExUS score tracks right atrial pressure in acute heart failure and shock

In acute heart failure and cardiogenic shock, VExUS tracked right atrial pressure and hepato-renal dysfunction, but discordance was…

Oct 22, 2026

Cardiology·JACC

Heart Failure Guidelines Update Adds Global Resource-Based Recommendations

Updated iCARDIO global heart failure guidelines address acute and chronic disease, newer therapies, and care pathways for limited-resource…

Oct 22, 2026

Cardiology

Trials, guidelines and practice across cardiovascular medicine.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.